Elypta

Solna, Sweden · Founded 2017 · Privately Held (backing)

Developer a metabolism-based liquid biopsy platform designed to prevent cancer mortality through earlier detection and closer monitoring. Elypta is based in Solna, Sweden and was founded in 2017. It has raised $29.8 million.

Last price · $/share
—
Implied valuation
—
Total raised
$29.8M
Last round
—

Who backs Elypta?

17 investors
InvestorType
Chalmers VenturesVenture capital
IndustrifondenVenture capital
Norrsken VCOther
The Roddenberry FoundationOther
3T Invest—
Bonnier Capital—
EIC Scaling Club—
EIT Health—
European Innovation Council (Belgium)—
Hillclimber—
+ 7 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Elypta investors

17 investors are on record for Elypta, including Chalmers Ventures, Industrifonden, Norrsken VC and The Roddenberry Foundation.

Free account
More of Elypta with a free account
  • ·The complete investor list: 17 names
  • ·Watch Elypta: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 17 firms already write checks for companies like Elypta. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View